Bernard Christenson Bravo, MD
Infectious Disease · Bayamon, PRNPI 1467577387
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,985 of the $11,315 with a category attached, or 61.7%. AbbVie accounts for 82.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $4,342 and has fallen 92.7% since, to $317 in 2025. Among infectious disease clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $221.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$9K
- Shionogi Inc$1K
- Johnson & Johnson$327
- Viiv Healthcare Company$134
- Takeda Pharmaceuticals U.S.A., Inc.$47
- Pfizer$35
- plus $50 from 2 others
What the payments were for
- Consulting fees$5074%
- Speaking & faculty fees$6,98562%
- Travel & lodging$1,92717%
- Food & beverage$1,89617%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 29 | $9,372 |
| Shionogi Inc | 10 | $1,350 |
| Johnson & Johnson | 6 | $327 |
| Viiv Healthcare Company | 2 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $47 |
| Pfizer | 1 | $35 |
| Merck | 1 | $25 |
| Novartis | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,315 in reported general payments places this provider in the 90th percentile of 127 infectious disease providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Bayamon
- Joel Munoz CoreanoBayamon$59K
- Ruth Soto-MalaveBayamon$11K
- Zelma Fuxench LopezBayamon$4K
- Eduardo Morfa RomeroBayamon$2K
- Patricia Pastor PerezBayamon$2K
- Melba ColonBayamon$847
- Marisel Bosques RosadoHato Rey$247K
- Jorge Santana BagurManati$180K
- Francisco AlvaradoCaguas$69K
- Jorge Bertran-PasarellHato Rey$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.